Search
Glaucoma Clinical Trials
A listing of 33 Glaucoma clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
1 - 12 of 33
There are currently 33 active clinical trials seeking participants for Glaucoma research studies. The states with the highest number of trials for Glaucoma participants are California, Texas, New York and Florida.
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Featured Offer
Lose Weight with GLP-1 Medications
Recruiting
Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.
Conditions:
Overweight
Overweight and Obesity
Obesity
Weight Loss
Morbid Obesity
The Role of Music in Enhancing Attention During Visual Field Exams for Pediatric Glaucoma Patients
Recruiting
The goal of the study is to see if the use of music improves attention during visual field exams for pediatric glaucoma patients.
Gender:
ALL
Ages:
Between 8 years and 17 years
Trial Updated:
07/29/2025
Locations: Wilmer Eye Institute, Bethesda, Maryland
Conditions: Glaucoma
A Prospective Study on the Efficacy of Direct Selective Laser Trabeculoplasty (DSLT) in Achieving >20% Intraocular Pressure (IOP) Reduction Without Medications at 6 Months in Naive, Untreated Glaucoma Patients
Recruiting
Background
Glaucoma is a progressive optic neuropathy characterized by elevated intraocular pressure (IOP), leading to irreversible vision loss. Current treatment strategies often involve medications, which can be challenging for patients due to adherence issues and side effects. Direct Selective Laser Trabeculoplasty (DSLT) represents a potential surgical alternative for managing IOP in patients with naive, untreated glaucoma. This study aims to evaluate the efficacy of DSLT in achieving signi... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/14/2025
Locations: Shafer Vision Institute, Plymouth Meeting, Pennsylvania
Conditions: Primary Open Angle Glaucoma, Glaucoma, Primary Open Angle Glaucoma or Ocular Hypertension
The Glaucoma and Retinopathy Screening Study
Recruiting
The goal of this clinical trial is to learn if a new screening approach including an artificial intelligence algorithm that analyzes fundus photographs, measurement of eye pressure and visual field testing works to screen for glaucoma.
Participants will:
Have an image of their fundus (back of the eye) taken as part of their diabetic eye screening Have a measurement of their eye pressure If needed, have a test of their side vision using a headset
Gender:
ALL
Ages:
40 years and above
Trial Updated:
07/11/2025
Locations: Brigham and Women's Primary Care Associates of Longwood, Boston, Massachusetts +3 locations
Conditions: Glaucoma
Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Recruiting
Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/10/2025
Locations: Glaukos Investigative Site, Grand Junction, Colorado +2 locations
Conditions: Glaucoma
Electrical Stimulation for Vision Neuroenhancement in Glaucoma
Recruiting
The purpose of the study is to evaluate the efficacy, transorbital alternating current stimulation (rtACS) using the EYETRONIC for the treatment in patients with glaucoma.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/09/2025
Locations: Byers Eye Institute at Stanford University, Palo Alto, California
Conditions: Glaucoma, Glaucoma Open-Angle
Village-Integrated Eye Worker Trial II
Recruiting
The vast majority of blindness is avoidable. The World Health Organization (WHO) estimates that 80% of cases of visual impairment could be prevented or reversed with early diagnosis and treatment. The leading causes of visual impairment are cataract and refractive error, followed by glaucoma, age-related macular degeneration (AMD), and diabetic retinopathy (DR). Loss of vision from these conditions is not inevitable; however, identifying cases early and linking cases with appropriate care remain... Read More
Gender:
ALL
Ages:
50 years and above
Trial Updated:
07/08/2025
Locations: University of California, San Francisco, San Francisco, California
Conditions: Age-related Macular Degeneration, Diabetic Retinopathy, Glaucoma
Electrical Stimulation for the Treatment of Optic Neuropathies
Recruiting
The overall aim of this study is to see whether long-term electrical stimulation with a home-stimulation device works well and is safe for the treatment of open-angle glaucoma. Open-Angle Glaucoma is a disease where the nerves in the back of your eye die off faster than expected regardless of your eye pressure.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/02/2025
Locations: Byers Eye Institute, Palo Alto, California
Conditions: Glaucoma, Glaucoma, Open-Angle, Optic Nerve Diseases
Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial
Recruiting
Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial (DECLARE) is a multi-center, outcome-masked, randomized clinical trial. The purpose of this study is to compare glaucoma drainage device implantation in the anterior chamber (front part of the eye) and sulcus (small space between iris and front chamber of the eye) in efforts to minimize cell loss in the eye.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
06/23/2025
Locations: University of California San Francisco, San Francisco, California +7 locations
Conditions: Glaucoma
24-hour Wear Performance and Safety Study of Smartlens miLens Contact Lens for IOP Monitoring
Recruiting
The goal of this clinical trial is to learn if a new contact lens device can record patterns in eye pressure for 24 hours in adults with glaucoma and in healthy participants.
The main questions it aims to answer are:
* Is the contact lens device able to detect patterns in eye pressure that happens naturally between nighttime and daytime?
* Are the contact lens recording patterns similar when repeated one week later?
* What eye problems do participants have when wearing contact lens for up to 2... Read More
Gender:
ALL
Ages:
Between 22 years and 80 years
Trial Updated:
05/22/2025
Locations: Nvision Clinical Reseacrh, LLC, Fullerton, California +2 locations
Conditions: Glaucoma, GLAUCOMA 1, OPEN ANGLE, D (Disorder), Ocular Hypertension, Ocular Hypertension (OH), Ocular Hypertension Glaucoma, IOP, Intraocular Pressure, Glaucoma Open-Angle, Glaucoma and Ocular Hypertension, Glaucoma Patients and Healthy Controls, Normal Tension Glaucoma (NTG)
Evaluate the Safety and Effectiveness of iSTAR Medical's MINIject™ Implant for Lowering Intraocular Pressure (IOP) in Subjects With Primary Open-angle Glaucoma.
Recruiting
Evaluate the safety and effectiveness of iSTAR Medical's MINIject™ implant for lowering intraocular pressure (IOP) in subjects with primary open-angle glaucoma.
Gender:
ALL
Ages:
46 years and above
Trial Updated:
05/21/2025
Locations: Arizona Advanced Eye Research Institute, Glendale, Arizona +36 locations
Conditions: Glaucoma
Hyperbaric Oxygen Therapy for Optic Neuropathies
Recruiting
The purpose of the study is to evaluate the neuroprotective efficacy of hyperbaric oxygen for the treatment in patients with optic neuropathy.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
05/20/2025
Locations: Byers Eye Institute, Palo Alto, California
Conditions: Optic Neuropathy, Glaucoma
An App-based Instructional Platform to Improve Eye Drop Recall
Recruiting
The goal of this interventional study is to assess whether an in-office, language-concordant instructional app improves drop regimen recall in a population of glaucoma patients who are on multi-drop regimens.
Participants will be divided into two groups -- those who use the app and those who do not. The app will have narrated information regarding the drop regimen, a quiz to test understanding of the regimen, and will enable a graphical printout of the eye drops and schedule.
At one month, bot... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
03/26/2025
Locations: San Francisco General Hospital, San Francisco, California
Conditions: Glaucoma
1 - 12 of 33